ClinicalTrials.Veeva

Menu

Polarization Sensitive Optical Coherence Tomography

S

Singapore Eye Research Institute

Status

Completed

Conditions

Myopia

Treatments

Device: Polarization sensitive optical coherence tomography (PS-OCT)

Study type

Observational

Funder types

Other

Identifiers

NCT05809674
R1819/61/2021

Details and patient eligibility

About

The purpose of the study is to use the polarization sensitive optical coherence tomography (PS-OCT) developed by Singapore Eye Research Institute, to evaluate the potential OCT scleral biomarkers capable of predicting risk of myopia progression.

Enrollment

178 patients

Sex

All

Ages

10 to 99 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

(Adult Cohort)

  • Aged 21 and above
  • Ability to provide informed consent
  • 42 normal controls: No diabetes and free from clinically relevant eye disease that interferes with the aim of the study i.e. glaucoma, diabetic retinopathy, age-related macular degeneration, uveitis, or vascular occlusive diseases
  • 76 subjects with pathological myopia (up to -12 dioptres) or staphyloma

(Children Cohort)

  • Aged 10 to 18
  • 23 subjects with low to moderate myopia (-0.75 to -6 dioptres)
  • 23 subjects with high myopia (more than -6 dioptres)
  • Ability of legal representative and subject to provide informed consent

Exclusion criteria

(Adult Cohort)

  • Unable to give consent
  • Subjects with visual acuity worse than 6/12
  • Diagnosis of clinically relevant eye disease that interferes with the aim of the study (e.g. diabetic retinopathy, hereditary macular disease, glaucoma, uveitis, or vascular occlusive diseases) or conditions that may potentially result in poor quality imaging scans (severe cataract, corneal haze/opacity)

Trial design

178 participants in 2 patient groups

Adult Cohort
Description:
* Aged 21 and above * Ability to provide informed consent * 42 normal controls: No diabetes and free from clinically relevant eye disease that interferes with the aim of the study i.e. glaucoma, diabetic retinopathy, age-related macular degeneration, uveitis, or vascular occlusive diseases * 76 subjects with pathological myopia (up to -12 dioptres) or staphyloma
Treatment:
Device: Polarization sensitive optical coherence tomography (PS-OCT)
Children Cohort
Description:
* Aged 10 to 18 * 23 subjects with low to moderate myopia (-0.75 to -6 dioptres) * 23 subjects with high myopia (more than -6 dioptres) * Ability of legal representative and subject to provide informed consent
Treatment:
Device: Polarization sensitive optical coherence tomography (PS-OCT)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems